Default company panoramic image
Ff9d0375 fa69 499a 82b4 6a30380379f2

Chromatan Corporation

Column-Free, Single-Use purification for large scale manufacturing of biological products.

  • Stage Product In Development
  • Industry Biotechnology
  • Location State College, PA, USA
  • Currency USD
  • Founded January 2009
  • Employees 3
  • Incorporation Type C-corp
  • Website chromatan.com

Company Summary

Chromatan Corporation is commercializing a new revolutionary column-free purification platform called “Countercurrent Tangential Chromatography” (CTC) which will replace column chromatography in large-scale manufacturing of antibodies and other biological products. Our technology is projected to provide customers significant cost savings (65%), as well as disposability and scalability to drug production companies around the world.

Team

  • Default avatar
    Oleg Shinkazh
    CEO
    Unconfirmed

    Oleg Shinkazh, founder and CEO of Chromatan and the inventor of “Countercurrent Tangential Chromatography” is a chemical and biotechnology engineer with 11 years of experience in the biotechnology industry, specializing in downstream processing and purification of biologics. Oleg has been with Chromatan since October 2009, leading technical and business development of the company.

  • Default avatar
    Dr. Andrew Zydney
    Board member
    Unconfirmed

    Dr. Andrew Zydney is the Chemical Engineering Department Head at Penn State University. He is one of the leading researchers in the bioseparations industry, with more than 150 publications in leading industry journals. Dr. Zydney supervises the technical partnership of Chromatan with Penn State, and has been an invaluable technical resource for the company.

  • Default avatar
    Boris Napadensky
    VP of Engineering
    Unconfirmed

    Boris Napadensky, VP of Engineering at ChromaTan, is a chemical engineer with 10 years of experience in leading the development and scale-up of new technologies. Boris is an accomplished technical manager with a lot of expertize in design and construction of new chemical process systems on lab, pilot and commercial scale. He is to join ChromaTan on January 16th, 2012. Boris is to lead design and construction of the Countercurrent Tangential Chrom

  • Default avatar
    Paul H. Silvis
    Board Member
    Unconfirmed

    Paul founded Restek (www.restek.com) in 1985 to manufacture innovative, high quality chromatography products. The company’s sales exceed $60 Million and continue to outpace competitors. Paul is Chromatan's largest investor and has been an invaluable adviser as a member of the board of directors

Advisors

  • Default avatar
    Vincent De Vito
    Lawyer
    Unconfirmed
    Default avatar
    Gary Bamat
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Phase 1 SBIR ,Natinal Institue of Health, $183,000
    Unconfirmed
    Default avatar
    Ben Franklin Technology Partners of Central Pennsylvania, $150,000
    Unconfirmed
    Default avatar
    Angel Round, June 2012, $228,000
    Unconfirmed